Welcome to CDC Stacks | Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma - 17484 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
  • Published Date:
    Jul 2009
  • Source:
    Emerg Infect Dis. 15(7):1088-1090.
Filetype[PDF - 455.36 KB]


Details:
No Related Documents.
You May Also Like:
  1. A Cross-Sectional Study of ‘Yaws’ in Districts of Ghana Which Have Previously Undertaken Azithromycin Mass Drug Administration for Trachoma Control
    Personal Author:
    Ghinai, Rosanna; El-Duah, Philip; Chi, Kai-Hua; Pillay, Allan; Solomon, Anthony W.; Bailey, Robin L.; Agana, Nsiire; Mabey, David C. W.; Chen, Cheng-Yen; Adu-Sarkodie, Yaw; Marks, Michael;
    Published:
    Jan 29 2015
    Source:
    PLoS Negl Trop Dis. 9(1).
    Description:
    Yaws, caused by Treponema pallidum ssp. pertenue, is reportedly endemic in Ghana. Mass distribution of azithromycin is now the cornerstone of the WHO yaws eradication campaign. Mass distribution of azithromycin at a lower target dose was previously u...
    File Type:
    Filetype[PDF - 1.41 MB]
  2. Short-Term Malaria Reduction by Single-Dose Azithromycin during Mass Drug Administration for Trachoma, Tanzania
    Personal Author:
    Schachterle, Stephen E.; Mtove, George; Levens, Joshua P.; Clemens, Emily; Shi, Lirong; Raj, Amrita; Dumler, J. Stephen; Munoz, Beatriz; West, Shelia; Sullivan, David J.;
    Published:
    Jun 2014
    Source:
    Emerg Infect Dis. 20(6):941-949.
    Description:
    Single-dose mass drug administration of azithromycin (AZT) is underway to eliminate trachoma worldwide. Studies in Ethiopia showed a reduction in all-cause childhood deaths after administration. To examine the effect of single-dose AZ MDA on prevalen...
    File Type:
    Filetype[PDF - 541.97 KB]
  3. Role of Chlamydia trachomatis in Miscarriage
    Personal Author:
    Baud, David; Goy, Genevieve; Jaton, Katia; Osterheld, Maria-Chiara; Blumer, Serafin; Borel, Nicole; Vial, Yvan; Hohlfeld, Patrick; Pospischil, Andreas; Greub, Gilbert;
    Published:
    Sep 2011
    Source:
    Emerg Infect Dis. 17(9):1630-1635.
    Description:
    To determine the role of Chlamydia trachomatis in miscarriage, we prospectively collected serum, cervicovaginal swab specimens, and placental samples from 386 women with and without miscarriage. Prevalence of immunoglobulin G against C. trachomatis w...
    File Type:
    Filetype[PDF - 220.30 KB]
  4. Recommendations for the prevention and management of chlamydia trachomatis infections, 1993
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    August 6, 1993
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 42, no.RR-12
    Description:
    Summary: In 1985, CDC published Policy Guidelines for Prevention and Control of Chlamydia trachomatis infections (1 ). Those guidelines highlighted the prevalence and morbidity of chlamydial infections and stressed the need to include antibiotics eff...
    File Type:
    Filetype[PDF - 434.88 KB]
  5. Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration
    Personal Author:
    Goodhew, Erica Brook; Morgan, Sheri Maria G; Switzer, Andrew J; Munoz, Beatriz; Dize, Laura; Gaydos, Charlotte; Mkocha, Harran; West, Sheila K; Wiegand, Ryan E; Lammie, Patrick J; Martin, Diana L;
    Published:
    Apr 22 2014
    Source:
    BMC Infect Dis. 2014; 14:216.
    Description:
    Background : Blinding trachoma, caused by the bacteria Chlamydia trachomatis, is a neglected tropical disease targeted for elimination by 2020. A major component of the elimination strategy is mass drug administration (MDA) with azithromycin. Current...
    File Type:
    Filetype[PDF - 562.06 KB]